NasdaqGS - Nasdaq Real Time Price ? USD Azenta, Inc. (AZTA) Follow Compare 44.13 -0.87 (-1.92%) As of 11:18 AM EDT. Market Open. All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations AZENTA ANNOUNCES APPOINTMENT OF JOHN P. MAROTTA AS CEO Azenta, Inc. (Nasdaq: AZTA) ("Azenta" or "the Company"), today announced that John P. Marotta will join the Company as President and CEO effective September 9, 2024, succeeding Dr. Stephen Schwartz, who is retiring following a distinguished tenure. Dr. Schwartz will remain as an advisor to Azenta to ensure a smooth and successful transition. PR Newswire ? last month AZTA -1.92% GENEWIZ from Azenta Life Sciences Celebrates 25 Years of Advancing Scientific Discoveries at GENEWIZ Week Event Azenta, Inc. (Nasdaq: AZTA) today announced that GENEWIZ Multiomics and Synthesis Solutions from Azenta Life Sciences will be hosting its 25th anniversary and the launch of its annual GENEWIZ Week event on September 16 - 20. GENEWIZ Week will showcase our commitment to providing cutting-edge solutions to researchers worldwide through a series of workshops, an awards program, and engaging prizes and promotions. PR Newswire ? 2 months ago AZTA -1.92% Azenta Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags Azenta ( NASDAQ:AZTA ) Third Quarter 2024 Results Key Financial Results Revenue: US$172.8m (up 4.1% from 3Q 2023). Net... Simply Wall St. ? 2 months ago AZTA -1.92% Azenta Reports Third Quarter Results for Fiscal 2024, Ended June 30, 2024 Azenta, Inc. (Nasdaq: AZTA) today reported financial results for the third quarter ended June 30, 2024. PR Newswire ? 2 months ago AZTA -1.92% Azenta Announces Fiscal 2024 Third Quarter Earnings Conference Call and Webcast Azenta, Inc. (Nasdaq: AZTA) will announce fiscal third quarter 2024 earnings which ended on June 30, 2024, on Tuesday, August 6, 2024, after the market closes. PR Newswire ? 2 months ago AZTA -1.92% FinnGen Selects Azenta to Propel Personalized Medicine for Population Health Study Azenta, Inc. (Nasdaq: AZTA) today announced its participation in the FinnGen project, a large-scale research initiative at the forefront of personalized medicine in Finland. The FinnGen project is a pioneering endeavor that has collected and is currently analyzing genomic and health data from a cohort of 500,000 Finnish biobank participants. PR Newswire ? 2 months ago AZTA -1.92% The past three years for Azenta (NASDAQ:AZTA) investors has not been profitable Many investors define successful investing as beating the market average over the long term. But in any portfolio... Simply Wall St. ? 3 months ago AZTA -1.92% Azenta Announces Collaboration with the Crohn's & Colitis Foundation to Support its Crohn's Disease and Ulcerative Colitis Clinical Research Azenta, Inc. (Nasdaq: AZTA) today announced it has been selected by the Crohn's & Colitis Foundation (the "Foundation") as its sample management services provider for two of its large-scale prospective research cohorts, CAPTURE IBD and IBD SIRQC, which investigate pediatric and surgical care for Crohn's disease and ulcerative colitis. Azenta will provide sample management services, including sample processing, analysis, logistics, and storage for these pivotal studies. PR Newswire ? 4 months ago AZTA -1.92% Azenta to Participate in the Jefferies Global Healthcare Conference Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the Jefferies Global Healthcare Conference in New York, NY, on Wednesday, June 5, 2024, which includes a presentation beginning at 11:00 am ET. The live webcast can be accessed through the Azenta investor relations website at https://investors.azenta.com/events. A replay of the webcast will be available following the event. PR Newswire ? 4 months ago AZTA -1.92% Azenta Opens the Doors to Its New Genomics Laboratory in Oxford, UK Azenta, Inc. (Nasdaq: AZTA) today announced the grand opening of the new Genomics Laboratory in Oxford, UK, expanding its global reach of GENEWIZ Multiomics & Synthesis Solutions further in the UK market. The new laboratory brings Azenta closer to UK-based researchers, providing advanced next-generation sequencing (NGS) platforms and a local team of top-tier scientists from Oxford. PR Newswire ? 5 months ago AZTA -1.92% Azenta Inc (AZTA) Q2 Fiscal 2024 Earnings: Revenue Growth Amid Challenges Revenue Surpasses Estimates, EPS Aligns with Projections GuruFocus.com ? 5 months ago AZTA -1.92% Azenta Announces CEO Succession Plan Azenta, Inc. (Nasdaq: AZTA) today announced a CEO succession plan, under which CEO and Board Director Dr. Stephen Schwartz will be retiring from Azenta after more than 14 years of service. Dr. Schwartz will continue to serve as CEO until a successor is appointed to ensure a smooth transition. PR Newswire ? 5 months ago AZTA -1.92% Azenta Reports Second Quarter Results for Fiscal 2024, Ended March 31, 2024 Azenta, Inc. (Nasdaq: AZTA) today reported financial results for the second quarter ended March 31, 2024. PR Newswire ? 5 months ago AZTA -1.92% Azenta Announces Fiscal 2024 Second Quarter Earnings Conference Call and Webcast Azenta, Inc. (Nasdaq: AZTA) will announce fiscal second quarter 2024 earnings which ended on March 31, 2024, on Wednesday, May 8, 2024, after the market closes. PR Newswire ? 5 months ago AZTA -1.92% Azenta, Inc. (NASDAQ:AZTA) Shares Could Be 35% Above Their Intrinsic Value Estimate Key Insights The projected fair value for Azenta is US$42.07 based on 2 Stage Free Cash Flow to Equity Azenta's... Simply Wall St. ? 6 months ago AZTA -1.92% Azenta Publishes its 2023 Environmental, Social, & Governance (ESG) Report Azenta, Inc. (Nasdaq: AZTA) today announced the publication of its annual Environmental, Social, & Governance ("ESG") report, highlighting the Company's ongoing commitment to advancing its strategy and actions aligned with key ESG priorities. The report includes ESG data for the Company's fiscal year ended September 30, 2023. PR Newswire ? 6 months ago AZTA -1.92% Azenta to Participate in the 23rd Annual Needham Virtual Healthcare Conference Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the 23rd Annual Needham Virtual Healthcare Conference, on Monday, April 8, 2024, which includes a presentation beginning at 12:45 pm ET. The live webcast can be accessed through the Azenta investor relations website at https://investors.azenta.com/events. A replay of the webcast will be available following the event. PR Newswire ? 6 months ago AZTA -1.92% Azenta to Participate in the Virtual KeyBanc Life Sciences & MedTech Investor Forum Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in Virtual KeyBanc Life Sciences & MedTech Investor Forum on Tuesday, March 19, 2024, which includes a presentation beginning at 12:45 pm ET. The live webcast can be accessed through the Azenta investor relations website at https://investors.azenta.com/events. A replay of the webcast will be available following the event. PR Newswire ? 7 months ago AZTA -1.92% Azenta Inc (AZTA) Faces Revenue Decline and EPS Drop in Q1 Fiscal 2024 Despite Challenges, Company Reports Positive Free Cash Flow and Progress in Cost Reduction Initiatives GuruFocus.com ? 8 months ago AZTA -1.92% Azenta Reports First Quarter Results for Fiscal 2024, Ended December 31, 2023 Azenta, Inc. (Nasdaq: AZTA) today reported financial results for the first quarter ended December 31, 2023. PR Newswire ? 8 months ago AZTA -1.92% Performance Overview Trailing total returns as of 10/16/2024, which may include dividends or other distributions. Benchmark is S&P 500 Return AZTA S&P 500 YTD -32.25% +22.10% 1-Year -11.78% +34.57% 3-Year -57.30% +30.25%
